Lin Cheng

5.2k total citations · 2 hit papers
75 papers, 3.4k citations indexed

About

Lin Cheng is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Lin Cheng has authored 75 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 13 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Surgery. Recurrent topics in Lin Cheng's work include Thyroid Cancer Diagnosis and Treatment (13 papers), Pluripotent Stem Cells Research (13 papers) and Glioma Diagnosis and Treatment (7 papers). Lin Cheng is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (13 papers), Pluripotent Stem Cells Research (13 papers) and Glioma Diagnosis and Treatment (7 papers). Lin Cheng collaborates with scholars based in China, United States and Ireland. Lin Cheng's co-authors include Shideng Bao, Jeremy N. Rich, Zhi Huang, Shu-Min Xiong, Qiulian Wu, Olga A. Guryanova, Min Wang, Yuewen Tang, Justin D. Lathia and Pei Yu and has published in prestigious journals such as Cell, JAMA and Nature Communications.

In The Last Decade

Lin Cheng

66 papers receiving 3.4k citations

Hit Papers

Glioblastoma Stem Cells Generate Vascular Pericytes to Su... 2013 2026 2017 2021 2013 2021 200 400 600

Peers

Lin Cheng
Anita C. Bellail United States
Bo Hu United States
Fengju Chen United States
Shuli Xia United States
Anita C. Bellail United States
Lin Cheng
Citations per year, relative to Lin Cheng Lin Cheng (= 1×) peers Anita C. Bellail

Countries citing papers authored by Lin Cheng

Since Specialization
Citations

This map shows the geographic impact of Lin Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Cheng more than expected).

Fields of papers citing papers by Lin Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Cheng. The network helps show where Lin Cheng may publish in the future.

Co-authorship network of co-authors of Lin Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Cheng. A scholar is included among the top collaborators of Lin Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Cheng. Lin Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ye, Feng, Liu Guang, Haiqing Li, & Lin Cheng. (2025). Target neutrophil heterogeneity and plasticity in cancer. Journal of Hematology & Oncology. 18(1). 79–79.
3.
Liu, Qianyi, Xinyu Li, Hui Xu, et al.. (2025). Therapeutic gene correction of HBB frameshift CD41-42 (-TCTT) deletion in human hematopoietic stem cells. PubMed. 3(1). 2–2. 2 indexed citations
4.
Cheng, Lin, et al.. (2025). Newborn Screening Using Genome Sequencing for Early Actionable Conditions. JAMA. 333(12). 1087–1087. 1 indexed citations
5.
Wu, Yaoxin, et al.. (2025). Benders decomposition for traveling salesman problem with drone: A space-time-state network perspective. Transportation Research Part C Emerging Technologies. 179. 105255–105255.
7.
Chen, Lini, Diandian Liu, Weicong Hong, et al.. (2025). Creating New Cis-Regulatory Elements of HBD to Reactivate Delta-Globin. Human Gene Therapy. 36(7-8). 765–773. 1 indexed citations
8.
Cheng, Lin, Wan‐Hsuan Chang, Hung‐Te Hsu, et al.. (2024). Spatheliachromen mitigates methylglyoxal-induced myotube atrophy by activating Nrf2, inhibiting ubiquitin-mediated protein degradation, and restoring mitochondrial function. European Journal of Pharmacology. 984. 177070–177070. 1 indexed citations
9.
Cheng, Lin, Zhuang Miao, Zhe Li, et al.. (2024). Cryo-EM structure of small-molecule agonist bound delta opioid receptor-Gi complex enables discovery of biased compound. Nature Communications. 15(1). 8284–8284. 7 indexed citations
10.
Wang, Guan, Yanglu Wang, Yulin Lyu, et al.. (2023). Highly efficient and rapid generation of human pluripotent stem cells by chemical reprogramming. Cell stem cell. 30(4). 450–459.e9. 77 indexed citations
11.
Zhao, Chang, Heli Wang, Ying Liu, et al.. (2023). Biased allosteric activation of ketone body receptor HCAR2 suppresses inflammation. Molecular Cell. 83(17). 3171–3187.e7. 29 indexed citations
12.
Wang, Guan, Yanglu Wang, Yulin Lyu, et al.. (2023). Chemical-induced epigenome resetting for regeneration program activation in human cells. Cell Reports. 42(6). 112547–112547. 9 indexed citations
13.
Zhang, Yi, Minhua Yu, Ying Jing, et al.. (2020). Baseline immunity and impact of chemotherapy on immune microenvironment in cervical cancer. British Journal of Cancer. 124(2). 414–424. 50 indexed citations
14.
Cheng, Lin, et al.. (2016). Chemical transdifferentiation: closer to regenerative medicine. Frontiers of Medicine. 10(2). 152–165. 7 indexed citations
15.
Zhang, Yu, Lin Cheng, Yajing Chen, et al.. (2016). Clinical predictor and circulating microRNA profile expression in patients with early onset post-stroke depression. Journal of Affective Disorders. 193. 51–58. 49 indexed citations
16.
Li, Jianqiang, et al.. (2014). A high efficiency gene disruption strategy using a positive–negative split selection marker and electroporation for Fusarium oxysporum. Microbiological Research. 169(11). 835–843. 16 indexed citations
17.
Cheng, Lin, Zhi Huang, Wenchao Zhou, et al.. (2013). Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth. Cell. 153(1). 139–152. 659 indexed citations breakdown →
18.
Cheng, Lin, Wenqing Chen, Dongmei Xu, et al.. (2010). Identification of the genecluster involved in muraymycin biosynthesis from Streptomyces sp. NRRL 30471. Molecular BioSystems. 7(3). 920–927. 46 indexed citations
19.
Huang, Zhi, Lin Cheng, Olga A. Guryanova, Qiulian Wu, & Shideng Bao. (2010). Cancer stem cells in glioblastoma—molecular signaling and therapeutic targeting. Protein & Cell. 1(7). 638–655. 183 indexed citations
20.
Cheng, Lin, Taiyuan Li, & Yi Zhang. (2004). Rapid Preparation of Total Nucleic Acids from E. coli for Multi-purpose Applications. BMB Reports. 37(3). 351–355. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026